tbuckley/cabot-search huggingface dataset:
Abstract 326: Comparison of Patients’ Subjective Sense of Well Being and Their Cardiopulmonary Exercise Test Results
Authors: Ayesha Bakhtiar, Adeel Yousphi, Adnaan Sheikh, Lan Yang, Shahkar A Khan, Esha Mahmood, Hemanshi Mistry, Amer Suleman
Journal: Circulation Research (2020)

Introduction: The cardiopulmonary exercise test (CPET) helps assess exercise tolerance in patients. The CPET is a better predictor of general health status and functional capacity (fc) when compared with resting cardiac and pulmonary function testing measurements (1). The test makes use of a bicycle ergometer with the patient being fitted with ECG leads, blood pressure cuff, pulse oximeter, and a face mask which determines the amount of oxygen consumed and carbon dioxide released. The predicted peak oxygen consumption per unit body weight per unit time (VO2max) is calculated based on patient’s sex, age, weight and height (2). Fc is measured as a percentage of VO2max that was actually consumed. Objective: Our study evaluates any relationship between the CPET fc results and patient’s sense of overall well-being, which provides a subjective measure of their quality of life. Methods: In this retrospective study, we randomly selected 299 patients who visited the clinic using electronic medical records from May-June 2019. There were 260 females and 39 males, with ages between 16-82 years. Patient history was analyzed to look for “overall health rating” scores; how they felt about their overall health on a scale of 1 to 10, with 1 denoting feeling the worst and 10 indicating feeling the best of their health. Their CPET fc results were analyzed at the same time, where values &lt;55% meant severely reduced fc, ≥55% but &lt;70% meant moderately reduced fc, ≥70% but &lt;80% meant mildly reduced fc, and ≥80% meant normal fc. Logistic regression was used to look for an association between the values of the overall health rating and CPET fc results, where patient’s age and sex were used as control variables. Results: With each score increase in the overall health rating, the odds of the fc value being normal than being mildly/moderately/severely reduced increases by 1.2 times, given the patient sex and age remain constant (95%CI (0.76,0.98), p = 0.019&lt;0.05). Conclusion: The results reveal a statistically significant association between the patients' overall health rating and their CPET fc results. The higher the numerical value of the overall health rating and the better the patients feel about their health, the greater the probability that the patient will also have a better CPET fc result. Thus the CPET fc can be used as an objective value to assess a patient’s overall well being.
Preliminary Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Subcutaneously (SC) Administered PF-06863135, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Authors: Alexander M. Lesokhin, Moshe Y. Levy, Andrew P. Dalovisio, Nizar J. Bahlis, Melhem Solh, Michael Sebag, Andrzej Jakubowiak, Yogesh S. Jethava, Caitlin L. Costello, Michael P. Chu, Michael R. Savona, Cristina Gasparetto, Suzanne Trudel, Jeffrey Chou, Chandrasekhar Udata, Cynthia Basu, Heike I. Krupka, Noopur S. Raje
Journal: Blood (2020)
ANGPTL2-Containing Exosomes from Vascular Endothelial Cells Promote Leukemia Development
Authors: Guohuan Sun, Dan Huang, Xiaoxin Hao, Xiaoxiao He, Zhaofeng Zheng, Chiqi Chen, Zhuo Yu, Li Xie, Shihui Ma, Ligen Liu, Bo Zhou, Hui Cheng, Junke Zheng, Tao Cheng
Journal: Blood (2020)
COVID-19 Clinical Trials
Authors: Bonnie Ky, Douglas L. Mann
Journal: JACC CardioOncology (2020)

The coronavirus disease-2019 (COVID-19) pandemic has resulted in a proliferation of clinical trials designed to slow the spread of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Many therapeutic agents that are being used to treat patients with COVID-19 are repurposed treatments for influenza, Ebola, or for malaria that were developed decades ago and are unlikely to be familiar to the cardiovascular and cardio-oncology communities. Here, we provide a foundation for cardiovascular and cardio-oncology physicians on the front line providing care to patients with COVID-19, so that they may better understand the emerging cardiovascular epidemiology and the biological rationale for the clinical trials that are ongoing for the treatment of patients with COVID-19.
The impact of COVID-19 on patients with asthma
Authors: José Luis Izquierdo, Carlos Almonacid, Yolanda González, Carlos Del Rio-Bermudez, Julio Ancochea, Remedios Cárdenas, Sara Lumbreras, Joan B. Soriano
Journal: European Respiratory Journal (2020)

Background An association between the severity of coronavirus disease 2019 (COVID-19) and the presence of certain chronic conditions has been suggested. However, unlike influenza and other viruses, the disease burden of COVID-19 in patients with asthma has been less evident. Objective To understand the impact of COVID-19 in patients with asthma. Methods Using big-data analytics and artificial intelligence through the SAVANA Manager clinical platform, we analysed clinical data from patients with asthma from January 1 to May 10, 2020. Results Out of 71 182 patients with asthma, 1006 (1.41%) suffered from COVID-19. Compared to asthmatic individuals without COVID-19, patients with asthma and COVID-19 were significantly older (55 versus 42 years), predominantly female (66% versus 59%), smoked more frequently and had higher prevalence of hypertension, dyslipidaemias, diabetes and obesity. Allergy-related factors such as rhinitis and eczema were less common in asthmatic patients with COVID-19 (p&lt;0.001). In addition, higher prevalence of these comorbidities was observed in patients with COVID-19 who required hospital admission. The use of inhaled corticosteroids (ICS) was lower in patients who required hospitalisation due to COVID-19, as compared to non-hospitalised patients (48.3% versus 61.5%; OR 0.58, 95% CI 0.44–0.77). Although patients treated with biologics (n=865; 1.21%) showed increased severity and more comorbidities at the ear, nose and throat level, COVID-19-related hospitalisations in these patients were relatively low (0.23%). Conclusion Patients with asthma and COVID-19 were older and at increased risk due to comorbidity-related factors. ICS and biologics are generally safe and may be associated with a protective effect against severe COVID-19 infection.
Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance
Authors: Chris Gale, Maria A Quigley, Anna Placzek, Marian Knight, Shamez Ladhani, Elizabeth S Draper, Don Sharkey, Cora Doherty, Helen Mactier, Jennifer J Kurinczuk
Journal: The Lancet Child & Adolescent Health (2020)

Babies differ from older children with regard to their exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, data describing the effect of SARS-CoV-2 in this group are scarce, and guidance is variable. We aimed to describe the incidence, characteristics, transmission, and outcomes of SARS-CoV-2 infection in neonates who received inpatient hospital care in the UK.We carried out a prospective UK population-based cohort study of babies with confirmed SARS-CoV-2 infection in the first 28 days of life who received inpatient care between March 1 and April 30, 2020. Infected babies were identified through active national surveillance via the British Paediatric Surveillance Unit, with linkage to national testing, paediatric intensive care audit, and obstetric surveillance data. Outcomes included incidence (per 10 000 livebirths) of confirmed SARS-CoV-2 infection and severe disease, proportions of babies with suspected vertically and nosocomially acquired infection, and clinical outcomes.We identified 66 babies with confirmed SARS-CoV-2 infection (incidence 5·6 [95% CI 4·3-7·1] per 10 000 livebirths), of whom 28 (42%) had severe neonatal SARS-CoV-2 infection (incidence 2·4 [1·6-3·4] per 10 000 livebirths). 16 (24%) of these babies were born preterm. 36 (55%) babies were from white ethnic groups (SARS-CoV-2 infection incidence 4·6 [3·2-6·4] per 10 000 livebirths), 14 (21%) were from Asian ethnic groups (15·2 [8·3-25·5] per 10 000 livebirths), eight (12%) were from Black ethnic groups (18·0 [7·8-35·5] per 10 000 livebirths), and seven (11%) were from mixed or other ethnic groups (5·6 [2·2-11·5] per 10 000 livebirths). 17 (26%) babies with confirmed infection were born to mothers with known perinatal SARS-CoV-2 infection, two (3%) were considered to have possible vertically acquired infection (SARS-CoV-2-positive sample within 12 h of birth where the mother was also positive). Eight (12%) babies had suspected nosocomially acquired infection. As of July 28, 2020, 58 (88%) babies had been discharged home, seven (11%) were still admitted, and one (2%) had died of a cause unrelated to SARS-CoV-2 infection.Neonatal SARS-CoV-2 infection is uncommon in babies admitted to hospital. Infection with neonatal admission following birth to a mother with perinatal SARS-CoV-2 infection was unlikely, and possible vertical transmission rare, supporting international guidance to avoid separation of mother and baby. The high proportion of babies from Black, Asian, or minority ethnic groups requires investigation.UK National Institute for Health Research Policy Research Programme.
Abstract 16402: Development and Validation of a Novel Non-Invasive Cuff-Less Blood Pressure Monitoring Device
Authors: Kazuhiro Sumitomo, Hideyuki Kato, Atsuhiro Kanno, Masakazu Suzuki, Takao Nakano, Ilya Fine, Ori Braitbart, Tatsuya Komaru, Naoyuki Hasebe
Journal: Circulation (2019)

Introduction: The cuff based blood pressure has a history of over 100 years, all the existing measurement techniques are cuff-based with drawbacks such as discontinuous in nature, patient comfort, ...
THU0239 Oropharyngeal dysfunction in systemic sclerosis
Authors: F Cozzi, F Pomerri, N Durigon, A Bullo, L Semerano, P Sfriso, S Todesco
Journal: Annals of the Rheumatic Diseases (2001)

<h3>Background</h3> Esophagopathy is one of the most frequent visceral organ involvements in Systemic Sclerosis (SSc). Fibrous tissue substitution of the visceral wall progressively compromises peristalsis and leads to lower oesophageal sphincter incompetence, with dysphagia and reflux esophagitis. The process most frequently involves the lower two thirds of the oesophagus, but in many patients, oropharynx and the upper third of the oesophagus can be involved as well. <h3>Objectives</h3> In order to evaluate this aspect of the disease, we submitted a group of sclerodermic patients to videofluorography with contrast agent, a technique that allows to study the oropharyngeal phase of deglutition. <h3>Methods</h3> We evaluated 36 SSc patients, 33 female, 3 male, mean age 52 yrs. (range 27–75), mean disease duration 8.5 yrs., 23 with limited SSc, 13 with diffuse SSc. They underwent videofluorography with barium sulphate, which allows to study either the oropharyngeal or the oesophageal phase of deglutition. <h3>Results</h3> In 31 patients (86.1%) we detected radiographic abnormalities, in 11 (30.6%) of both phases, in 16 (44.4%) of the esophageal phase only, in 4 (11.1%) of the oropharingeal phase only. The oropharyngeal abnormalities, detected in 15(41.7%) patients, comprised: incompetence of palatoglossus histmus and palatopharyngeus histmus, stasis of the contrast agent in the valleculae and pyriform recesses, and its penetration inside laryngeal haditus. <h3>Conclusion</h3> Our study demonstrates that in many SSc patients, even the first phase of deglutition, the oropharyngeal one, is altered. Tissue fibrosis involves even oropharyngeal structures, compromising deglutition in the first phase with higher risk of ab ingestis phenomena.
MDS/CMML with <i>TET2</i> or <i>IDH</i> mutation Are Associated with Systemic Inflammatory and Autoimmune Diseases (SIAD) and T Cell Dysregulation
Authors: Lin-Pierre Zhao, Maxime Boy, Celia Azoulay, Emmanuelle Clappier, Marie Sébert, Ludivine Amable, Jihene Klibi, Kamel Benlagha, Marion Espeli, Karl Balabanian, Claude Preudhomme, Alice Marceau, Raphael Itzykson, Arsène Mékinian, Olivier Fain, Antoine Toubert, Pierre Fenaux, Nicolas Dulphy, Lionel Ades
Journal: Blood (2020)
Serological Prevalence of Sars-Cov-2 Infection Among Chronic Myeloid Leukemia Patients Undergoing Tyrosine Kinase Inhibitor Treatment in Italy (COVID-19-HEM Study)
Authors: Massimiliano Bonifacio, Gianni Binotto, Mario Tiribelli, Maria Cristina Miggiano, Malgorzata Monika Trawinska, Luigi Scaffidi, Eros Di Bona, Daniela Damiani, Vanessa Velotta, Giulia Ceccarelli, Elisabetta Pierdomenico, Mariella Loschirico, Maria Vittoria Dubbini, Maddalena Cordioli, Marco Ruggeri, Renato Fanin, Gianpietro Semenzato, Evelina Tacconelli, Giovanni Pizzolo, Mauro Krampera
Journal: Blood (2020)
Ex-Vivo Autologous Stem Cell Gene Therapy Clinical Trial for Mucopolysaccharidosis Type IIIA: Trial in Progress - NCT04201405
Authors: Jane L Kinsella, Robert F Wynn, Brian Bigger, Adrian J. Thrasher, Claire Booth, Karen Buckland, Natalia Izotova, Stewart Rust, Daniel Weisberg, Heather J Church, Kathryn L Brammeier, Karen L Tylee, Ceri Jones, Helena Lee, Laura Ford, Atusa Sadegholnejat, Stuart Ellison, Simon A Jones
Journal: Blood (2020)
Genome Wide Association Analysis of Iron Overload in the Trans-Omics for Precision Medicine (TOPMed) Sickle Cell Disease Cohorts
Authors: Fayuan Wen, Angela Rock, Juan Salomon-Andonie, Gulriz Kurban, Xiaomei Niu, Songping Wang, Xu Zhang, Victor R. Gordeuk, Yingze Zhang, Seyed Mehdi Nouraie, Mark T Gladwin, Allison Ashley-Koch, Marilyn J. Telen, Brian Custer, Shannon Kelly, Carla Luana Dinardo, Ester Sabino, Quenna Wong, James G. Taylor, Sergei Nekhai
Journal: Blood (2020)
Congenital Neutropenia Is Also Associated with a High Cancer Risk: A Study from the French Severe Chronic Neutropenia Registry
Authors: Jean Donadieu, Fares bou Mitri, Blandine Beaupain, Yves Bertrand, Pierre Simon Rohrlich, Nathalie Aladjidi, Alexia Rouland, Felipe Suarez, Andre Vanoli, Jean Fraisse, Olivier Hermine, Philippe Descamps, Sylvie François, Hélène Lapillonne, Marlène Pasquet, Matthieu Patient, Ilona Okhremchuck, Didier Blaise, Faezeh Legrand, Claire Fieschi, Flore Sicre de Fontbrune, Sarah cohen Beaussant, didier Simon Kamioner, Francoise Bachelerie, Claire Deback, Christine Bellanne-Chantelot, Jean-François Emile
Journal: Blood (2020)
Incidence and Therapeutic Implications of Germline <i>TP53</i> Mutations in Hypodiploid Childhood Acute Lymphoblastic Leukemia: A Retrospective Analysis of the Italian Cohort
Authors: Laura Rachele Bettini, Claudia Saitta, Barbara Buldini, Geertruij Te Kronnie, Stefano Rebellato, Daniela Silvestri, Elena Barisone, Andrea Pession, Marco Rabusin, Concetta Micalizzi, Franco Locatelli, Carmelo Rizzari, Maria Grazia Valsecchi, Andrea Biondi, Grazia Fazio, Giovanni Cazzaniga
Journal: Blood (2020)
Bone Marrow Stromal Antigen 2 Is Critical for IFNy-Dependent Hematopoietic Stem Cell Activation
Authors: Marcus A Florez, Katie A Matatall, Youngjae Jeong, Laura Ortinau, Paul Shafer, Anne Lynch, Roman Jaksik, Marek Kimmel, Dongsu Park, Katherine Y. King
Journal: Blood (2020)
Reply to Yi Sun, Fengxiang Sun, Qiang Wei, Jin Huang, and Ruiqi Duan’s Letter to the Editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304–6
Authors: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg
Journal: European Urology (2020)
Gene Therapy for Fanconi Anemia, Complementation Group a: Updated Results from Ongoing Global Clinical Studies of RP-L102
Authors: Agnieszka Czechowicz, Rajni Agarwal, Julián Sevilla, Paula Río, Susana Navarro, Brian C Beard, Kenneth M Law, Grace Choi, Miriam Zeini, Eileen Nicoletti, John E Wagner, Claire Booth, Jonathan D Schwartz, Juan A Bueren, Maria Grazia Roncarolo
Journal: Blood (2020)
Abstract PO-092: Immune profiling of the tumor microenvironment using multiplexed ion beam imaging (MIBI)
Authors: Jason Ptacek, Srimoyee Ghosh, Lourdes Pablo, Bin Feng, Hailei Zhang, Yari Sigal, Jay G. Tarolli, Murat Aksoy, Yi Zhang, Rachel Finck, Jessica Finn
Journal: Cancer Research (2020)

Abstract The growing application of immunotherapy and its ability, or inability, to modulate the tumor microenvironment (TME) has exposed a need for techniques capable of simultaneously tracking large numbers of biomarkers in complex tissue at sub-cellular resolution. To address this, MIBI uses tissue processed similar to standard immunohistochemistry (IHC) methods but with the advantage of being able to stain the tissue simultaneously with a panel of up to 40 metal labeled antibodies. The expression of proteins is imaged by MIBI in a single scan at subcellular spatial resolution by combining the high resolution of an ion beam and the sensitivity of time-of-flight secondary ion mass spectrometry (ToF-SIMS). To characterize the immune infiltrates present in a set of 10 non-small-cell lung carcinoma (NSCLC) samples, a panel of 22 metal labeled antibodies was used to stain the tissue. The stained tissue was then analyzed by MIBI and the masses of detected species were assigned to target biomolecules given the unique label of each antibody. Multi-step processing and segmentation utilizing highly expressed nuclear, membrane, and cytoplasmic markers were performed to accurately determine cell boundaries and enable quantitative analyses of marker expression, cell classification, and the spatial relationships between cell types. Results comparing the abundance of tumor cells, vascular cells, and immune cell subsets between samples identified “cold” tumors with few immune cells and inflamed samples that varied in the type of immune populations present. Immune checkpoint markers (LAG3, PD-1, PD-L1, TIM-3) were also quantified at single cell resolution. In conclusion, this study shows that MIBI offers high-parameter capability necessary to (1) identify the wide range of cell types present within the complex tumor immune landscape, (2) the spatial relationships between these different cell populations, and (3) the expression status of key immunoregulatory proteins. Citation Format: Jason Ptacek, Srimoyee Ghosh, Lourdes Pablo, Bin Feng, Hailei Zhang, Yari Sigal, Jay G. Tarolli, Murat Aksoy, Yi Zhang, Rachel Finck, Jessica Finn. Immune profiling of the tumor microenvironment using multiplexed ion beam imaging (MIBI) [abstract]. In: Proceedings of the AACR Virtual Special Conference on Tumor Heterogeneity: From Single Cells to Clinical Impact; 2020 Sep 17-18. Philadelphia (PA): AACR; Cancer Res 2020;80(21 Suppl):Abstract nr PO-092.
A Phase II, Open-Label, Single Arm Trial to Assess the Efficacy and Safety of the Combination of Tisagenlecleucel and Ibrutinib in Mantle Cell Lymphoma (TARMAC)
Authors: Adrian Minson, Nada Hamad, Jason P Butler, David Alan Westerman, David Ritchie, Piers Blombery, John F. Seymour, Constantine S. Tam, Michael Dickinson
Journal: Blood (2020)
The Dual PI3Kδγ Inhibitor Duvelisib Potently Inhibits IL-6 Production and Cytokine Release Syndrome (CRS) While Maintaining CAR-T Function in Vitro and In Vivo
Authors: Parmeshwar N Amatya, Alun J Carter, Julie K Ritchey, Jessica Niswonger, Matthew L Cooper, Jonathan A Pachter, John F. DiPersio
Journal: Blood (2020)
<i>Nfkbiz</i> 3′ UTR Mutations Confer Selective Growth Advantage and Affect Drug Response in Diffuse Large B-Cell Lymphoma
Authors: Sarah E Arthur, Nicole Thomas, Christopher Rushton, Jeffrey Tang, Miguel Alcaide, Shannon Healy, Adele Telenius, Anja Mottok, David W. Scott, Christian Steidl, Ryan D Morin
Journal: Blood (2020)
New Guideline Calls for Cervical Cancer Screening to Begin at Age 25 Years
Authors: Anita Slomski
Journal: JAMA (2020)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Circulating Biomarkers of COVID-19-Triggered Endotheliopathy: From Conjecture to Certainty
Authors: Ana Belen Moreno-Castaño, Sara Fernandez, Marta Palomo, Patricia Molina, Julia Martinez-Sanchez, Sergi Torramade-Moix, Helena Ventosa, Ferran Segui, Gines Escolar, Enric Carreras, Jose Maria Nicolas, Edward Richardson, David Garcia-Bernal, Carmelo Carlo-Stella, Jose Maria Moraleda, Paul G. Richardson, Maribel Diaz-Ricart, Pedro Castro
Journal: Blood (2020)
Peripheral Blood CD34+ Donor Chimerism Is Superior to CD3+ Donor Chimerism for Predicting Relapse Following Allogeneic Stem Cell Transplantation for Myeloid Malignancies
Authors: Tongted Das, Daniel North, Shaun Fleming, David Kliman, Andrew Spencer, Andrew H. Wei, Sushrut S. Patil, Jacueline Widjaja, Maureen O'Brien, David J. Curtis
Journal: Blood (2020)
Epidemiology and Management of Immune Thrombocytopenia in Adult Patients in Algeria: A Non-Interventional, Longitudinal, Nationwide Estimation Study
Authors: Mohamed-Amine Bekadja, Mohamed Bradai, Hocine Ait Ali, Selma Hamdi, Nadia Boudjerra, Mahdia Hocine Saidi, Fatiha Grifi, Djamel Saidi, Naima Mesli, Zahia Zouaoui, Nourredine Lakhdari, Nemra Mehalhal, Noureddine Sidimansour, Ryma Tiaiba, Sarah Lakehal, Hossam A Saad
Journal: Blood (2020)
Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) at Admission Are Predictors for Worse Functional Outcome in Cerebral Venous Sinus Thrombosis
Authors: Binbin Zheng, Qian Wang, Sridevi Rajeeve, Biyue Dai, Cynthia Zevallos, Darko Quispe-Orozco, Mudassir Farooqui, Jorge Ares-Morcuende, Santiago Ortega-Gutierrez
Journal: Blood (2020)
Rationale for and Results of a Phase I Study of the TGF-β 1/3 Inhibitor AVID200 in Subjects with Myelofibrosis: MPN-RC 118 Trial
Authors: John Mascarenhas, Heidi E. Kosiorek, Lilian Varricchio, Rupali Bhave, Andrew T. Kuykendall, Rami Komrokji, Aaron T. Gerds, Jeanne M. Palmer, Amelia R. Gabler, Lonette Sandy, Anna Rita Migliaccio, Mohamed E Salama, Rona Singer Weinberg, Maureen O'Connor-McCourt, Gilles Tremblay, Paul I. Nadler, Amylou C. Dueck, Ruben A. Mesa, Ronald Hoffman
Journal: Blood (2020)
<i>SF3B1</i> Mutations and Not <i>TP53</i> Are Associated with Poor Outcomes in Patients with Del(5q) Myelodysplastic Syndromes (MDS)
Authors: Onyee Chan, Najla Al Ali, David A. Sallman, Eric Padron, Jeffrey E. Lancet, Rami Komrokji
Journal: Blood (2020)
Secondary Erythrocytosis Is Phenotypically Distinct from Polycythemia Vera but Associated with Comparable Rates of Thrombosis at Diagnosis
Authors: Eliane Nguyen, Natasha Szuber, Michael Harnois, Lambert Busque, Luigina Mollica, Sarit E Assouline, Ines Chamakhi, Harold J. Olney, Shireen Sirhan
Journal: Blood (2020)